|
||||||||
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
SELECT PUBLICATIONS
Giordano SH et al. Congestive heart failure (CHF) in older women treated with anthracycline (A) chemotherapy (C). Proc ASCO 2006;Abstract 521.
Mano MS et al. Adjuvant anthracycline-based chemotherapy for early breast cancer: Do the dose and schedule matter? Cancer Treat Rev 2005;31(2):69-78. Abstract
Mazouni C et al. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. Ann Oncol 2007;18(5):874-80. Abstract
Miller KD et al. A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: A trial coordinated by the Eastern Cooperative Oncology Group (E2100). Presentation. San Antonio Breast Cancer Symposium 2005;Abstract 3.
Paik S et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-34. Abstract
Pinder MC et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 2007;25(25):3808-15. Abstract
Press MF et al. Alterations of topoisomerase II-alpha gene in human breast cancer and its association with responsiveness to anthracycline-based chemotherapy. Proc ASCO 2007;Abstract 524.
Telli ML et al. Trastuzumab-related cardiotoxicity: Calling into question the concept of reversibility. J Clin Oncol 2007;25(23):3525-33. Abstract
 |
 |
EDITOR'S NOTE
Survivors
Neil Love, MD
- Select publications
INTERVIEWS
Ian E Smith, MD
- Select publications
Charles L Vogel, MD
- Select publications
Sandra M Swain, MD
- Select publications
Paul E Goss, MD, PhD
- Select publications
Hannah M Linden, MD
- Select publications
Breast Cancer Update:
A CME Audio Series and Activity
 |
 |
 |
 |
 |
